Optimizing Antibiotic Therapy in the Treatment of Gram-negative Infections: Recent Advances for Improved Clinical and Economic Outcomes

A continuing medical education activity provided by NAMCP and AAMCN

Turning the Tide on Serious Gram-negative Infections: Managed Care Considerations for Improved Patient Outcomes is a two-part webinar series focusing on the latest developments in the
treatment and prevention of gram-negative infections

This is Part 1 of the series focusing on optimizing therapy in gram-negative infections

This activity is an archive from the webinar held July 22, 2020

This activity is valid from August 1, 2020 to August 1, 2022

Instructions for CME/NCPD: Complete the pre-test, listen to the audio and view the slides, complete the post test, complete the evaluation form and hit submit. You will be asked to enter your name and email address on the pre-test, evaluation and post-test. If you close your internet browser without completing the post test, you will have ONE more opportunity to complete. A score of 70% must be achieved on the post test to receive continuing education credits. If you do not pass the post test after two attempts, you will not be eligible to try again. Once you complete the evaluation form and score 70% or higher on your post test, you will automatically be given your certificate.

To print or save your certificate, you will need to click on the “download” button and either print or save.


Audience: This activity is intended for healthcare professionals practicing in managed care environments.

This activity is supported by an educational grant from
Merck Sharp & Dohme Corp.

Gram-negative bacteria represent an ongoing global healthcare challenge, with changing epidemiology and resistance patterns resulting in increased morbidity and mortality rates among hospitalized patents. Infections caused by Gram-negative bacteria are a significant concern and can have serious consequences. Multidrug-resistant and carbapenem-resistant Gram-negative infections are increasing in prevalence, and their management is complicated by limited treatment options. New antibiotics for preventing and managing these serious infections have recently been introduced, and other agents are in late stages of clinical development. These webinars will take a closer look what managed care professionals need to know about these new options.

Upon completion of this activity, participants will be able to:

  • Summarize the clinical and economic burden of Gram-negative infections and challenges associated with its management

  • Describe the epidemiology and mechanisms of drug resistance among Gram-negative infections

  • Outline patient and clinical factors that increase risks for resistant Gram-negative infections

  • Compare and contrast new and emerging antibiotic options for treating serious Gram-negative infections

  • Describe strategies to optimize antimicrobial therapy to ensure effectiveness and reduce resistance

Faculty: Roy F. Chemaly, MD, MPH, FIDSA, FACP
Professor of Medicine
Director, Infection Control Section
Director, Clinical Virology Research
UT MD Anderson Cancer Center


Dr. Chemaly serves as a consultant for Merck, Shionogi, Inc, The Medicines Company, and Xenex. He has received research grants from Merck and Xenex. His presentation has been peer reviewed for any bias.
  Planning Committee:
Bill Williams, MD has no real or perceived financial relationships to disclose.
Jeremy Williams has no real or perceived financial relationships to disclose.
Jacqueline Cole, RN, MS, CMCN has no real or perceived financial relationships to disclose.

NAMCP and/or the presenter has copyright or has received permissions for use of materials provided in this activity.

Accreditation & Designation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association of Managed Care Physicians (NAMCP) and American Association of Managed Care Nurses (AAMCN). The National Association of Managed Care Physicians is accredited by the ACCME to provide continuing medical education for physicians.

NAMCP designates this enduring material for a maximum of 1 AMA PRA Category 1 credit(s)TM. Each
physician should claim credit commensurate with the extent of their participation in the activity.

The American Association of Managed Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

Nurses who complete this activity and achieve a passing score will receive 1 hour in nursing continuing professional development.

This activity has been approved by the American Board of Managed Care Nursing for 1.0 contact hours toward CMCN recertification requirements.

This activity is supported by an educational grant from
Merck Sharp & Dohme Corp.

NAMCP and/or this website does not provide medical advice, diagnosis or treatment. NAMCP does not endorse or imply endorsement of the content on any linked website. This website is to be used as an informational resource. With any health related concern, consult with your physician or healthcare professional.

Click Here To Continue